Interim results from a phase 2 randomized, double-blind, placebo-controlled trial of tazbentetol demonstrated early signals of efficacy across schizophrenia symptom domains.
Interim results from a phase 2 randomized, double-blind, placebo-controlled trial of tazbentetol demonstrated early signals of efficacy across schizophrenia symptom domains.
This infographic focuses on clinician perceptions of adverse events associated with the use of olanzapine and how they rated proposed strategies to help maintain therapy when it is otherwise effective. It covers clinician-ranked options such...
This infographic focuses on clinician perceptions of adverse events associated with the use of olanzapine and how they rated proposed strategies to help maintain therapy when it is otherwise effective. It covers clinician-ranked options such...
This video focuses on clinician perceptions of adverse events associated with the use of olanzapine and how they rated proposed strategies to help maintain therapy when it is otherwise effective. It covers clinician-ranked options such as...
This video focuses on clinician perceptions of adverse events associated with the use of olanzapine and how they rated proposed strategies to help maintain therapy when it is otherwise effective. It covers clinician-ranked options such as...
This infographic reviews clinician perceptions of where a commonly used second-generation antipsychotic performs best. It also outlines common clinical scenarios in which respondents report preferring this option, translating perceptions into...
This infographic reviews clinician perceptions of where a commonly used second-generation antipsychotic performs best. It also outlines common clinical scenarios in which respondents report preferring this option, translating perceptions into...
